親記事
引用 |
|
History <a href=" http://www.allsportsevents.com/Results/other_results/para-que-sirve-el-medicamento-trental-de-400-mg.pdf ">trental 600 mg a rilascio modificato</a> The case specifically involves Myriad, a company that had patented genes BRCA1 and BRCA2, which are linked to breast and ovarian cancers. Their patents allowed them to have a monopoly on diagnostic genetic testing for hereditary breast and ovarian cancers and, according to the court, the "patents would, if valid, give it the exclusive right to isolate an individual's BRCA1 and BRCA2 genes … [a process] necessary to conduct genetic testing."
|